Nightingale Health partners with Genom to roll out blood-based chronic disease risk test in Croatia

• Nightingale Health formed a partnership with Croatia’s Genom to distribute the Nightingale Health Check across Genom’s clinic and laboratory network.
• Genom will market the test to healthcare providers; Nightingale Health will analyze blood samples, marking its entry into the Croatian market.
• The companies target a rollout across the network later in 2026, aiming for nationwide use in Croatia.
• Three pilots have been completed, with demand reported from both clinics and laboratories.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nightingale Health Oyj published the original content used to generate this news brief on September 09, 2026, and is solely responsible for the information contained therein.